Clinical Trial

Efficacy and Safety of Tamsulosin for Children with Posterior Urethral Valve.

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated December 20, 2024 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
To determine whether there is a role for Tamsulosin, A Selective Alpha-1 Adrenergic Blocker, as therapy in children with Posterior Urethral Valve post valve ablation , and whether there are side effects involved.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-12-14.
Status change: Active, Not Recruiting → Recruiting 2024-12-19
Trial Details
NCT Number NCT06737016
Lead Sponsor Mansoura University
Conditions Posterior Urethral Valve
Enrollment 50 participants
Start Date 2024-11-01
Primary Completion 2026-05 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2024-12-20